Amedisys Total Liabilities 2010-2024 | AMED

Amedisys total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Amedisys Annual Total Liabilities
(Millions of US $)
2023 $940
2022 $870
2021 $881
2020 $756
2019 $621
2018 $234
2017 $297
2016 $273
2015 $271
2014 $272
2013 $354
2012 $276
2011 $338
2010 $420
2009 $436
Amedisys Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $939
2024-06-30 $938
2024-03-31 $947
2023-12-31 $940
2023-09-30 $934
2023-06-30 $922
2023-03-31 $814
2022-12-31 $870
2022-09-30 $913
2022-06-30 $962
2022-03-31 $888
2021-12-31 $881
2021-09-30 $989
2021-06-30 $724
2021-03-31 $784
2020-12-31 $756
2020-09-30 $845
2020-06-30 $923
2020-03-31 $760
2019-12-31 $621
2019-09-30 $609
2019-06-30 $643
2019-03-31 $663
2018-12-31 $234
2018-09-30 $280
2018-06-30 $344
2018-03-31 $293
2017-12-31 $297
2017-09-30 $286
2017-06-30 $313
2017-03-31 $274
2016-12-31 $273
2016-09-30 $275
2016-06-30 $283
2016-03-31 $295
2015-12-31 $271
2015-09-30 $272
2015-06-30 $265
2015-03-31 $256
2014-12-31 $272
2014-09-30 $299
2014-06-30 $339
2014-03-31 $364
2013-12-31 $354
2013-09-30 $377
2013-06-30 $235
2013-03-31 $251
2012-12-31 $276
2012-09-30 $304
2012-06-30 $317
2012-03-31 $325
2011-12-31 $338
2011-09-30 $335
2011-06-30 $411
2011-03-31 $423
2010-12-31 $420
2010-09-30 $416
2010-06-30 $442
2010-03-31 $438
2009-12-31 $436
2009-09-30 $445
2009-06-30 $441
2009-03-31 $488
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.767B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 0.00
Quest Diagnostics (DGX) United States $17.088B 17.32
DaVita (DVA) United States $12.452B 16.10
Encompass Health (EHC) United States $9.516B 22.43
Chemed (CHE) United States $7.874B 24.20
Elanco Animal Health (ELAN) United States $5.749B 13.68
RadNet (RDNT) United States $5.382B 119.18
Option Care Health (OPCH) United States $3.899B 18.48
LifeStance Health (LFST) United States $2.789B 0.00
Addus HomeCare (ADUS) United States $2.383B 27.96
Astrana Health (ASTH) United States $1.896B 25.92
U.S Physical Therapy (USPH) United States $1.378B 36.23
Pennant (PNTG) United States $0.940B 38.03
Aveanna Healthcare Holdings (AVAH) United States $0.885B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.040B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00